Login / Signup

Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD).

Mai SekiToshiaki NakanoShigeru TanakaYuta MatsukumaKouta FunakoshiToshiaki OhkumaTakanari Kitazono
Published in: Clinical and experimental nephrology (2023)
This clinical trial was registered at the University Hospital Medical Information Network (UMIN) Center (UMIN-CTR: UMIN000042284).
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • randomized controlled trial
  • clinical trial
  • study protocol
  • newly diagnosed
  • ejection fraction
  • healthcare
  • patient reported outcomes
  • phase ii
  • patient reported
  • phase iii